22 December 2022
Interview with Dr. Danièle Noël—Editorial Board Member of Bioengineering
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
Name: Dr. Danièle Noël |
We had the pleasure of speaking with Dr. Danièle Noël, Editorial Board Member of Bioengineering (ISSN: 2306-5354), to discuss the recent research trends in the field and her personal career development. We hope you enjoy the interview.
Dr. Danièle Noël is currently Research Director at Inserm at the Institute for Regenerative Medicine and Biotherapies (IRMB) in Montpellier. She received her Ph.D. in health biology from Bordeaux University in 1992. She completed a postdoctoral fellowship at the Institute of Molecular Genetics in Montpellier in the field of recombinant retrovirology and gene therapy (1992–1999). She then moved to IRMB to work in cell therapy and became a professor in 2011. She is currently leading the group, “Organoids, Mesenchymal stromal cells and Extracellular vesicles for osteoarticular diseases therapies”, which includes 11 staff members. Her main interests are the biology of mesenchymal stromal cells and their application in the treatment of osteoarticular diseases and systemic sclerosis.
Her main focuses are:
She has authored more than 180 publications (h-index: 64; citations: 16310) and is currently a partner in three European programs.
The following is a short interview with Dr. Danièle Noël:
1. What are your research areas?
Mesenchymal stromal cells; extracellular vesicles; osteo-articular diseases; and therapies.
2. What are the latest developments in your research field?
Extracellular vesicles from mesenchymal stromal cells for the development of new acellular therapies in various therapeutic applications.
3. Can you briefly share your career development story? For example, what cases have influenced you the most?
I have held an academic position at the French National Institute for Health since 2007, where I integrated a laboratory as a senior researcher and, since 2011, I have become a research director leading a research group of more than 12 people.
4. Do you have any valuable suggestions you would like to share with young students and early career researchers?
Keep motivated to develop your own research projects and lead a research group.
5. What do you think of the development of Open Access in publishing?
I think it is a great opportunity to share your research results to a very large community. I totally agree with Open Access for research.
We are thankful for Dr. Noël's time and support of Bioengineering.